» Articles » PMID: 33804294

Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro

Overview
Journal Pathogens
Date 2021 Apr 3
PMID 33804294
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) is detectable in saliva from asymptomatic individuals, suggesting a potential benefit from the use of mouth rinses to suppress viral load and reduce virus spread. Published studies on the reduction of SARS-CoV-2-induced cytotoxic effects by mouth rinses do not exclude antiseptic mouth rinse-associated cytotoxicity. Here, we determined the effect of commercially available mouth rinses and antiseptic povidone-iodine on the infectivity of replication-competent SARS-CoV-2 viruses and of pseudotyped SARS-CoV-2 viruses. We first determined the effect of mouth rinses on cell viability to ensure that antiviral activity was not a consequence of mouth rinse-induced cytotoxicity. Colgate Peroxyl (hydrogen peroxide) exhibited the most cytotoxicity, followed by povidone-iodine, chlorhexidine gluconate (CHG), and Listerine (essential oils and alcohol). The potent antiviral activities of Colgate Peroxyl mouth rinse and povidone-iodine were the consequence of rinse-mediated cellular damage when the products were present during infection. The potency of CHG was greater when the product was not washed off after virus attachment, suggesting that the prolonged effect of mouth rinses on cells impacts the antiviral outcome. To minimalize mouth rinse-associated cytotoxicity, mouth rinse was largely removed from treated viruses by centrifugation prior to infection of cells. A 5% (/) dilution of Colgate Peroxyl or povidone-iodine completely blocked viral infectivity. A similar 5% (/) dilution of Listerine or CHG had a moderate suppressive effect on the virus, but a 50% (/) dilution of Listerine or CHG blocked viral infectivity completely. Mouth rinses inactivated the virus without prolonged incubation. The new infectivity assay, with limited impacts of mouth rinse-associated cytotoxicity, showed the differential effects of mouth rinses on SARS-CoV-2 infection. Our results indicate that mouth rinses can significantly reduce virus infectivity, suggesting a potential benefit for reducing SARS-CoV-2 spread.

Citing Articles

Investigating the effectiveness of commercially available mouthwash on SARS-CoV-2 in vivo using viable virus titre as the primary outcome. A randomised controlled trial.

Seymour D, Forshaw G, Porteous M, Mawer D, Wiggins F, Mitchell A Access Microbiol. 2024; 6(7).

PMID: 39130730 PMC: 11316591. DOI: 10.1099/acmi.0.000722.v3.


efficacy of 2% povidone iodine, chlorhexidine gluconate, and herbal extract mouthwash on SARS-CoV-2 viral load in saliva: A randomized clinical trial.

Nazrine S, Kulal R, Shivaprasad B, Janardhanan N J Indian Soc Periodontol. 2024; 27(6):607-611.

PMID: 38434502 PMC: 10906800. DOI: 10.4103/jisp.jisp_469_22.


Effect of 1% HO on Three Salivary Stress Biomarkers, Cortisol, Alpha-Amylase, and sIgA.

Jirakittayakorn N, Tamboon E, Mitrirattanakul S Int Dent J. 2023; 74(2):343-351.

PMID: 37985342 PMC: 10988260. DOI: 10.1016/j.identj.2023.10.014.


Efficacy of different mouthwashes against COVID-19: A systematic review and network meta-analysis.

Sbricoli L, Schiavon L, Brunello G, Brun P, Becker K, Sivolella S Jpn Dent Sci Rev. 2023; 59:334-356.

PMID: 37854066 PMC: 10579871. DOI: 10.1016/j.jdsr.2023.09.003.


The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution.

Wu C, Yang Y, Lin Y, Shu L, Cheng Y, Liu H Heliyon. 2023; 9(7):e17701.

PMID: 37483781 PMC: 10359827. DOI: 10.1016/j.heliyon.2023.e17701.


References
1.
Anderson D, Sivalingam V, Kang A, Ananthanarayanan A, Arumugam H, Jenkins T . Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Infect Dis Ther. 2020; 9(3):669-675. PMC: 7341475. DOI: 10.1007/s40121-020-00316-3. View

2.
Meiller T, Silva A, Ferreira S, Jabra-Rizk M, Kelley J, DePaola L . Efficacy of Listerine Antiseptic in reducing viral contamination of saliva. J Clin Periodontol. 2005; 32(4):341-6. PMC: 7166778. DOI: 10.1111/j.1600-051X.2005.00673.x. View

3.
Rogers T, Zhao F, Huang D, Beutler N, Burns A, He W . Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science. 2020; 369(6506):956-963. PMC: 7299280. DOI: 10.1126/science.abc7520. View

4.
Xie X, Muruato A, Lokugamage K, Narayanan K, Zhang X, Zou J . An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe. 2020; 27(5):841-848.e3. PMC: 7153529. DOI: 10.1016/j.chom.2020.04.004. View

5.
Baqui A, Kelley J, Jabra-Rizk M, DePaola L, Falkler W, Meiller T . In vitro effect of oral antiseptics on human immunodeficiency virus-1 and herpes simplex virus type 1. J Clin Periodontol. 2001; 28(7):610-6. DOI: 10.1034/j.1600-051x.2001.028007610.x. View